Human microsatellite DNA mimicking oligodeoxynucleotides down-regulate TLR9-dependent and -independent activation of human immune cells

Molecular Immunology

Volumn 46, Issue 7, 2009, Pages 1387-1396

  Hu, Dali ^a   Su, Xuejin ^a   Sun, Ran ^a   Yang, Guang ^a   Wang, Huaying ^a   Ren, Jiling ^a   Sun, Luguo ^a   Wu, Xiuli ^a   Hu, Xiaoping ^a   Yu, Yongli ^a   Wang, Liying ^a  

^a Basic Medical College   (China)

Author keywords

Human PBMC; Immunoregulation; Oligodeoxynucleotide

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; INTERFERON; MICROSATELLITE DNA; OLIGODEOXYNUCLEOTIDE DERIVATIVE; TOLL LIKE RECEPTOR 9;

ARTICLE; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; IMMUNOSTIMULATION; INTERFERON PRODUCTION; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; BLOOD CELLS; CELL PROLIFERATION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CPG ISLANDS; DNA; DOWN-REGULATION; HUMANS; IMMUNITY, CELLULAR; MICROSATELLITE REPEATS; MOLECULAR MIMICRY; OLIGONUCLEOTIDES; TOLL-LIKE RECEPTOR 9; VERO CELLS;

EID: 62549141777     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.12.008     Document Type: Article

References (52)

1. Bao M., Zhang Y., Wan M., et al. Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotide. Clin. Immunol. 118 (2006) 180
2. Barrat F.J., Meeker T., Gregorio J., et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202 (2005) 1131
3. Beltinger C., Saragovi H.U., Smith R.M., et al. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J. Clin. Invest. 95 (1995) 1814
4. Bennett P. Demystified...microsatellites. Mol. Pathol. 53 (2000) 177
5. Bennett R.M., Gabor G.T., and Merritt M.M. DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA. J. Clin. Invest. 76 (1985) 2182
6. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430 (2004) 257
7. Butler M., Crooke R.M., Graham M.J., et al. Phosphorothioate oligodeoxynucleotides distribute similarly in class A scavenger receptor knockout and wild-type mice. J. Pharmacol. Exp. Ther. 292 (2000) 489
8. Dib C., Fauré S., Fizames C., et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380 (1996) 152
9. Dong L., Ito S., Ishii K.J., et al. Suppressive oligonucleotides protect against collagen-induced arthritis in mice. Arthritis Rheum. 50 (2004) 1686
10. Dong L., Ito S., Ishii K.J., et al. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB × NZW mice. Arthritis Rheum. 52 (2005) 651
11. Gelman A.E., and Kreisel D. MyD88 is required for the differentiation of recipient monocytes into dendritic cells and macrophages in orthotopic lung grafts. J. Immunol. 178 (2007) 102.2
12. Giacomini C.P., Leung S.Y., Chen X., et al. A gene expression signature of genetic instability in colon cancer. Cancer Res. 65 (2005) 9200
13. Goldstein D.R., Tesar B.M., Akira S., and Lakkis F.G. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J. Clin. Invest. 111 (2003) 1571
14. Gur-Arie R., Cohen C.J., Eitan Y., et al. Simple sequence repeats in Escherichia coli: abundance, distribution, composition, and polymorphism. Genome Res. 10 (2000) 62
15. Gursel I., Gursel M., Yamada H., et al. Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J. Immunol. 171 (2003) 1393
16. Gursel M., Gursel I., Mostowski H.S., and Klinman D.M. CXCL16 influences the nature and specificity of CpG-induced immune activation. J. Immunol. 177 (2006) 1575
17. Haas T., Metzger J., Schmitz F., et al. The DNA sugar backbone 2′ deoxyribose determines toll-like receptor 9 activation. Immunity 28 (2008) 315
18. Halpern M.D., and Pisetsky D.S. In vitro inhibition of murine IFN gamma production by phosphorothioate deoxyguanosine oligomers. Immunopharmacology 29 (1995) 47
19. Hartmann G., and Krieg A.M. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164 (2000) 944
20. Hemmi H., Takeuchi O., Kawai T., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740
21. Ho P.P., Fontoura P., Ruiz P.J., et al. An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems. J. Immunol. 171 (2003) 4920
22. Hwang M.N., Kim K.S., Choi Y.W., Jou I., and Yoon S. PMA activates Stat3 in the Jak/Stat pathway and induces SOCS5 in rat brain astrocytes. Mol. Cells. 23 (2007) 94
23. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 409 (2001) 860
24. Ishii K.J., and Akira S. Innate immune recognition of, and regulation by, DNA. Trends Immunol. 27 (2006) 525
25. Kanzler H., Barrat F.J., Hessel E.M., and Coffman R.L. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat. Med. 13 (2007) 552
26. Kimura Y., Sonehara K., Kuramoto E., et al. Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN. J. Biochem. 116 (1994) 991
27. Klinman D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4 (2004) 249
28. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20 (2002) 709
29. Krieg A.M., Yi A.K., Matson S., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546
30. Krieg A.M., Wu T., Weeratna R., et al. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. 95 (1998) 12631
31. Krug A. Nucleic acid recognition receptors in autoimmunity. Handbook Exp. Pharmacol. (2008) 129
32. Krug A., Rothenfusser S., Hornung V., et al. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 31 (2001) 2154
33. LaRosa D.F., Rahman A.H., and Turka L.A. The innate immune system in allograft rejection and tolerance. J. Immunol. 178 (2007) 7503
34. Lee S.W., Song M.K., Baek K.H., et al. Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials. J. Immunol. 165 (2000) 3631
35. Li Y., Wong K.K., Matsueda S., et al. Mitogen stimulation activates different signaling pathways in early- and late-divided T cells as revealed by cDNA microarray analysis. Int. J. Mol. Med. 18 (2006) 1127
36. Liang H., Nishioka Y., Reich C.F., Pisetsky D.S., and Lipsky P.E. Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98 (1996) 1119
37. Liang H., Reich C.F., Pisetsky D.S., and Lipsky P.E. The role of cell surface receptors in the activation of human B cells by phosphorothioate oligonucleotides. J. Immunol. 165 (2000) 1438
38. Loke S.L., Stein C.A., Zhang X.H., et al. Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 3474
39. Mannon R.B., Nataraj C., and Pisetsky D.S. Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides. Cell Immunol. 201 (2000) 14
40. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6 (2006) 823
41. Marshall J.D., Fearon K., Abbate C., et al. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J. Leukoc. Biol. 73 (2003) 781
42. Reddy P.S., and Housman D.E. The complex pathology of trinucleotide repeats. Curr. Opin. Cell. Biol. 9 (1997) 364
43. Rothenfusser S., Tuma E., Endres S., and Hartmann G. Plasmacytoid dendritic cells: the key to CpG. Hum. Immunol. 63 (2002) 1111
44. Shirota H., Gursel I., Gursel M., et al. Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shock. J. Immunol. 174 (2005) 4579
45. Subramanian S., Mishra R.K., and Singh L. Genome-wide analysis of microsatellite repeats in humans: their abundance and density in specific genomic regions. Genome Biol. 4 (2003) R13
46. Thornley T.B., Phillips N.E., Beaudette-Zlatanova B.C., et al. Type 1 IFN mediates cross-talk between innate and adaptive immunity that abrogates transplantation tolerance. J. Immunol. 179 (2007) 6620
47. Tóth G., Gáspári Z., and Jurka J. Microsatellites in different eukaryotic genomes: survey and analysis. Genome Res. 10 (2000) 967
48. Wagner H. Bacterial CpG DNA activates immune cells to signal infectious danger. Adv. Immunol. 73 (1999) 329
49. Wagner H. Endogenous TLR ligands and autoimmunity. Adv. Immunol. 91 (2006) 159
50. Yakubov L.A., Deeva E.A., Zarytova V.F., et al. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 6454
51. Yamada H., Gursel I., Takeshita F., et al. Effect of suppressive DNA on CpG-induced immune activation. J. Immunol. 169 (2002) 5590
52. Zhu F.G., Reich C.F., and Pisetsky D.S. The role of the macrophage scavenger receptor in immune stimulation by bacterial DNA and synthetic oligonucleotides. Immunology 103 (2001) 226